Mode
Text Size
Log in / Sign up
N/A N=40 Randomized Supportive Care

Effect of VR on Pain and Patient Satisfaction in Adults Receiving GNRFA

Pain · Patient Satisfaction

Enrolled (actual)
40
Serious AEs
0.0%
Results posted
Jul 2025
Primary outcome: Primary: Peak Pain Intensity During Genicular RFA Procedure — 75.8; 70.6 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Soothe VR (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of California, Irvine
Primary completion
Sep 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Peak Pain Intensity During Genicular RFA Procedure
75.8; 70.6
PRIMARY
Patient Satisfaction With VR Device
93.4
SECONDARY
Patient Anxiety During Genicular RFA Procedure
67.5; 55
SECONDARY
Provider Satisfaction During Procedure
60.8; 91.7
SECONDARY
Use of Additional Local Anesthetic During Genicular RFA Procedure
5; 3; 15; 17
SECONDARY
Provider Perception of Patient's Pain During Genicular RFA Procedure
70.8; 36.9
SECONDARY
Prior Knee Radiofrequency Ablation
0; 0; 20; 20
SECONDARY
Prior Experience With Virtual Reality (VR)
5; 5; 15; 15
SECONDARY
Side Effects Associated With Virtual Reality During Genicular RFA Procedure
0; 0; 20; 20
SECONDARY
Duration of Time Spent Thinking About Pain During Genicular RFA Procedure

Summary

The study team aims to investigate whether implementing virtual reality therapy (VRT) during Genicular nerve radiofrequency ablation (GNRFA) procedure will provide better alleviation of procedural pain and augmented satisfaction for patients.

Eligibility Criteria

Inclusion Criteria

  • Patients aged 18 or older
  • Patients Undergoing a genicular nerve radiofrequency ablation
  • Patients who have previously received nerve blocks or radiofrequency ablation procedures may be included

Exclusion Criteria

  • Requiring sedation during procedure
  • Cognitive impairment or dementia
  • History of recent stroke, epilepsy, psychosis, or claustrophobia
  • Blindness or deafness
  • Refusal to use the headset
  • Isolation status for infection control
  • Motion sickness or active nausea/vomit
  • Pregnancy (Pregnancy testing point of care available for females of child bearing age)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05468398). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search